Nina N. Brodsky

Nina N. Brodsky

Auto-generated profile, based on publicly available information

Nina N. Brodsky

Section of Critical Care Medicine, Department of Pediatrics, Yale School of Medicine; New Haven, CT 06520, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2007 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SHSteven M. Holland
Steven M. Holland
FDFrank R. DeLeo
Frank R. DeLeo
HEHouda Z. Elloumi
Houda Z. Elloumi
AHAmy P. Hsu
Amy P. Hsu
GUGulbu Uzel
Gulbu Uzel
BGBodo Grimbacher
Bodo Grimbacher
The hyper-IgE syndrome (or Job's syndrome) is a rare disorder of immunity and connective tissue characterized by dermatitis, boils, cyst-forming pneumonias, elevated serum IgE levels, retained primary dentition, and bone abnormalities. Inheritance is autosomal dominant; sporadic cases are also found. We collected longitudinal clinical data on patients with the hyper-IgE syndrome and their families and assayed the levels of cytokines secreted by stimulated leukocytes and the gene expression in resting and stimulated cells. These data implicated the signal transducer and activator of transcription 3 gene (STAT3) as a candidate gene, which we then sequenced. We found increased levels of proinflammatory gene transcripts in unstimulated peripheral-blood neutrophils and mononuclear cells from patients with the hyper-IgE syndrome, as compared with levels in control cells. In vitro cultures of mononuclear cells from patients that were stimulated with lipopolysaccharide, with or without interferon-γ, had higher tumor necrosis factor α levels than did identically treated cells from unaffected persons (P=0.003). In contrast, the cells from patients with the hyper-IgE syndrome generated lower levels of monocyte chemoattractant protein 1 in response to the presence of interleukin-6 (P=0.03), suggesting a defect in interleukin-6 signaling through its downstream mediators, one of which is STAT3. We identified missense mutations and single-codon in-frame deletions in STAT3 in 50 familial and sporadic cases of the hyper-IgE syndrome. Eighteen discrete mutations, five of which were hot spots, were predicted to directly affect the DNA-binding and SRC homology 2 (SH2) domains. Mutations in STAT3 underlie sporadic and dominant forms of the hyper-IgE syndrome, an immunodeficiency syndrome involving increased innate immune response, recurrent infections, and complex somatic features.

26 May 2023 in Science Immunology
Verified
Journal Article
Closed access
ABAnis Barmada
Anis Barmada
JKJon Klein
Jon Klein
ARAnjali Ramaswamy
Anjali Ramaswamy
NBNina N. Brodsky
Nina N. Brodsky
JJJillian R. Jaycox
Jillian R. Jaycox
CLCarrie L. Lucas
Carrie L. Lucas
Rare immune-mediated cardiac tissue inflammation can occur after vaccination, including after SARS-CoV-2 mRNA vaccines. However, the underlying immune cellular and molecular mechanisms driving this pathology remain poorly understood. Here, we investigated a cohort of patients who developed myocarditis and/or pericarditis with elevated troponin, B-type natriuretic peptide, and C-reactive protein levels as well as cardiac imaging abnormalities shortly after SARS-CoV-2 mRNA vaccination. Contrary to early hypotheses, patients did not demonstrate features of hypersensitivity myocarditis, nor did they have exaggerated SARS-CoV-2–specific or neutralizing antibody responses consistent with a hyperimmune humoral mechanism. We additionally found no evidence of cardiac-targeted autoantibodies. Instead, unbiased systematic immune serum profiling revealed elevations in circulating interleukins (IL-1β, IL-1RA, and IL-15), chemokines (CCL4, CXCL1, and CXCL10), and matrix metalloproteases (MMP1, MMP8, MMP9, and TIMP1). Subsequent deep immune profiling using single-cell RNA and repertoire sequencing of peripheral blood mononuclear cells during acute disease revealed expansion of activated CXCR3 + cytotoxic T cells and NK cells, both phenotypically resembling cytokine-driven killer cells. In addition, patients displayed signatures of inflammatory and profibrotic CCR2 + CD163 + monocytes, coupled with elevated serum-soluble CD163, that may be linked to the late gadolinium enhancement on cardiac MRI, which can persist for months after vaccination. Together, our results demonstrate up-regulation in inflammatory cytokines and corresponding lymphocytes with tissue-damaging capabilities, suggesting a cytokine-dependent pathology, which may further be accompanied by myeloid cell–associated cardiac fibrosis. These findings likely rule out some previously proposed mechanisms of mRNA vaccine–-associated myopericarditis and point to new ones with relevance to vaccine development and clinical care.

1 December 2020 in Trends in Microbiology
Verified
Journal Article
Closed access
NBNina N. Brodsky
Nina N. Brodsky
ARAnjali Ramaswamy
Anjali Ramaswamy
CLCarrie L. Lucas
Carrie L. Lucas

21 May 2020 in Journal of Human Genetics
Verified
Journal Article
Closed access
PDF file
NBNina N. Brodsky
Nina N. Brodsky
OBOksana Boyarchuk
Oksana Boyarchuk
TKTetyana Kovalchuk
Tetyana Kovalchuk
THTetyana Hariyan
Tetyana Hariyan
ARAndrew Rice
Andrew Rice
CLCarrie L. Lucas
Carrie L. Lucas

28 July 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
NBNina N. Brodsky
Nina N. Brodsky
MCMonisha Chakder
Monisha Chakder
DKDinesh Babu Uthaya Kumar
Dinesh Babu Uthaya Kumar
ABAnis Barmada
Anis Barmada
JWJulia Wang
Julia Wang
CLCarrie L. Lucas
Carrie L. Lucas
Neonates and infants are distinct in their clinical and cellular responses to viral infections, with neonatal CD8 + T cells displaying innate-like characteristics and a low threshold for T cell receptor activation. However, specific molecular programs that drive these unique responses are incompletely understood, particularly in humans, and targetable pathways to modulate viral illness in this vulnerable population remain to be elucidated. Early-life immune responses may be developmentally programmed to prioritize avoidance of tissue immunopathology, especially while maternal immunoglobulin provides passive immunity. We set out to define the unique response characteristics and transcription factor landscape of neonatal human CD8 + T cells. Here, we report evidence that naïve neonatal human CD8 + T cells are poised for an accelerated effector switch, with elevations of killer cell lectin-like receptor G1 (KLRG1), killer cell lectin-like receptor B1 (KLRB1/CD161), Fc epsilon receptor I-gamma ( FCER1G ), DNAX accessory molecule-1 (DNAM1/CD226), granzymes, tumor necrosis factor alpha (TNFα), interleukin 2 (IL-2), and glycolysis compared to naïve adult CD8 + T cells. Further, rapid proliferation and cell death occur upon activation of neonatal CD8 + T cells, with cell viability largely rescued by IL-2 or IL-7. These features are coupled with a unique transcription factor landscape, including high expression of thymocyte selection associated high mobility group box (TOX) and HELIOS ( IKZF2 ), and these signatures continue in postnatal life until at least 2 mo of age. We conclude that early-life human CD8 + T cells maintain a unique transcriptional state associated with an accelerated effector switch and short-lived effector program, revealing key nodes of regulation relevant for the unique immunobiology of neonatal humans.

26 December 2025 in Journal of Human Immunity
Verified
Journal Article
Open access
NBNina N. Brodsky
Nina N. Brodsky
AKAlan Kennedy
Alan Kennedy
DGDaniel Glaser
Daniel Glaser
LJLauren Jeffries
Lauren Jeffries
WJWeizhen Ji
Weizhen Ji
SLSaquib Lakhani
Saquib Lakhani
Cytotoxic T lymphocyte antigen 4 (CTLA-4) is a key immune checkpoint receptor that regulates T cell activation through ligand competition and transendocytosis. Heterozygous loss-of-function variants in CTLA4 result in CTLA-4 haploinsufficiency with autoimmune infiltration (CHAI), characterized by immune dysregulation and autoimmunity. We report a multigenerational family carrying a novel heterozygous CTLA4 variant, c.654T>A (p.Tyr218*), which truncates the cytoplasmic tail. Affected individuals presented with recurrent infections and autoimmune manifestations. Patient T cells showed reduced CTLA-4 expression at baseline and after stimulation, suggesting impaired stability. Jurkat cells expressing CTLA-4 Y218* exhibited enhanced degradation, partially rescued by lysosomal inhibition, and reduced transendocytosis of CD80. Together, these findings suggest that the CTLA-4 p.Tyr218* variant compromises protein stability and ligand uptake, contributing to CTLA-4 haploinsufficiency and immune dysregulation. This work broadens the spectrum of CTLA4 variants and underscores the importance of the C-terminal cytoplasmic domain in CTLA-4 function and immune regulation.